Biological imaging in clinical oncology—introduction Yasumasa Nishimura Introduction to Invited Review Articles 14 June 2016 Pages: 617 - 618
Tumor hypoxia: a new PET imaging biomarker in clinical oncology Nagara TamakiKenji Hirata Review Article 14 November 2015 Pages: 619 - 625
Biological imaging in clinical oncology: radiation therapy based on functional imaging Yo-Liang LaiChun-Yi WuK. S. Clifford Chao Invited Review Article 06 July 2016 Pages: 626 - 632
Perspectives of Japanese oncologists on the health economics of innovative cancer treatments Tomoyuki TakuraMikihiro FujiyaYutaka Kohgo Original Article 14 December 2015 Pages: 633 - 641
A prospective study on neurocognitive effects after primary radiotherapy in high-grade glioma patients Raphael BodensohnStefanie CorradiniMaximilian Niyazi Original Article 22 December 2015 Pages: 642 - 650
Prognostic significance of NADPH oxidase-4 as an indicator of reactive oxygen species stress in human retinoblastoma Lata SinghNeeru SainiSeema Kashyap Original Article 08 February 2016 Pages: 651 - 657
Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma Goshi NishimuraKenichiro YabukiNobuhiko Oridate Original Article 28 December 2015 Pages: 658 - 667
Meta-analysis supporting noninferiority of oxaliplatin plus S-1 to cisplatin plus S-1 in first-line treatment of advanced gastric cancer (G-SOX study): indirect comparison with S-1 alone Chikuma HamadaYasuhide YamadaIchinosuke Hyodo Original Article 05 January 2016 Pages: 668 - 675
Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study Norio ItokawaMasanori AtsukawaKatsuhiko Iwakiri Original Article 23 December 2015 Pages: 676 - 683
Colorectal cancer in young patients: is it a distinct clinical entity? Hadar GoldvaserOfer PurimBaruch Brenner Original Article 28 January 2016 Pages: 684 - 695
UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer Yoshinori MiyataTetsuo TouyamaMitsuaki Manabe Original Article Open access 28 December 2015 Pages: 696 - 703
Erratum to: UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer Yoshinori MiyataTetsuo TouyamaMitsuaki Manabe Erratum 05 July 2016 Pages: 704 - 704
S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102) Yuji MiyamotoAkihito TsujiYoshihiko Maehara Original Article 08 January 2016 Pages: 705 - 712
Prevalence of laparoscopic surgical treatment and its clinical outcomes in patients with familial adenomatous polyposis in Japan Hideki UenoHirotoshi KobayashiHideyuki Ishida Original Article 28 January 2016 Pages: 713 - 722
Type C2 radical hysterectomy may improve outcomes of locally advanced mucinous adenocarcinoma of the uterine cervix Shinichi OkameAtsumi KojimaTakayoshi Nogawa Original Article 22 December 2015 Pages: 723 - 729
Clinical outcomes of abnormal cervical cytology and human papillomavirus-related lesions in patients with organ transplantation: 11-year experience at a single institution Yusuke TanakaYutaka UedaTadashi Kimura Original Article 22 December 2015 Pages: 730 - 734
Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study Masahiro KagabuTadahiro ShojiToru Sugiyama Original Article 19 January 2016 Pages: 735 - 740
Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy Munetaka TakekumaYuka KasamatsuYasuyuki Hirashima Original Article 08 February 2016 Pages: 741 - 747
Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinoma Masahiro NozawaKoichi SugimotoHirotsugu Uemura Original Article 22 December 2015 Pages: 748 - 755
Robot-assisted radical cystectomy is a promising alternative to open surgery in the Japanese population with a high rate of octogenarians Hideto IwamotoTetsuya YumiokaAtsushi Takenaka Original Article 20 January 2016 Pages: 756 - 763
Favorable outcome of intraoperative radiotherapy to the primary site in patients with metastatic prostate cancer Toshihiro KandaSyohei FukudaKazunori Kihara Original Article 11 January 2016 Pages: 764 - 772
A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer Hideyuki AkazaHirotsugu UemuraSeiji Naito Original Article Open access 21 January 2016 Pages: 773 - 782
Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer Takashi MizowakiYoshiki NorihisaMasahiro Hiraoka Original Article 03 February 2016 Pages: 783 - 790
Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors Terukazu NakamuraAkihiro KawauchiTsuneharu Miki Original Article 23 December 2015 Pages: 791 - 795
Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in Japan Arata TsutsumidaAkira TakahashiDai Ogata Original Article 13 January 2016 Pages: 796 - 800
Marriage and fertility in long-term survivors of childhood, adolescent and young adult (AYA) high-grade sarcoma Tsukasa YonemotoMiyako TakahashiTakeshi Ishii Original Article 20 January 2016 Pages: 801 - 807
Atypical and malignant granular cell tumors in Japan: a Japanese Musculoskeletal Oncology Group (JMOG) study Jungo ImanishiYasuo YazawaSusumu Joyama Original Article 13 January 2016 Pages: 808 - 816